Characterization of weaning-induced breast involution in women: implications for young women's breast cancer.

Breast cancer Cancer microenvironment Cancer prevention Developmental biology Target identification

Journal

NPJ breast cancer
ISSN: 2374-4677
Titre abrégé: NPJ Breast Cancer
Pays: United States
ID NLM: 101674891

Informations de publication

Date de publication:
2020
Historique:
received: 27 03 2020
accepted: 17 09 2020
entrez: 21 10 2020
pubmed: 22 10 2020
medline: 22 10 2020
Statut: epublish

Résumé

In rodents, weaning-induced mammary gland involution supports increased mammary tumor incidence, growth, and progression to metastasis. Further, the protumor attributes of gland involution are COX-2 dependent and mitigated by short-duration non-steroidal anti-inflammatory drugs (NSAIDs), suggesting a potential prevention strategy. However, the transition from lactation to postweaning breast involution has not been rigorously evaluated in healthy women. Here we queried breast biopsies from healthy women (

Identifiants

pubmed: 33083533
doi: 10.1038/s41523-020-00196-3
pii: 196
pmc: PMC7568540
doi:

Types de publication

Journal Article

Langues

eng

Pagination

55

Subventions

Organisme : NCI NIH HHS
ID : P30 CA046934
Pays : United States
Organisme : NCI NIH HHS
ID : P30 CA069533
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA169175
Pays : United States

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Competing interestsThe authors declare no competing interests.

Références

Nat Med. 2011 Aug 07;17(9):1109-15
pubmed: 21822285
Clin Breast Cancer. 2003 Oct;4(4):280-5
pubmed: 14651773
Am J Pathol. 2006 Feb;168(2):608-20
pubmed: 16436674
Cancer Causes Control. 1996 Jul;7(4):487-8
pubmed: 8813438
Development. 2012 Jan;139(2):269-75
pubmed: 22129827
Development. 1996 Jan;122(1):181-93
pubmed: 8565829
Breast Cancer Res Treat. 2013 Apr;138(2):549-59
pubmed: 23430224
Am J Anat. 1989 May;185(1):19-32
pubmed: 2782275
Cell Metab. 2018 Aug 7;28(2):282-288.e3
pubmed: 29909970
Am J Pathol. 2010 Mar;176(3):1241-55
pubmed: 20110414
EMBO Mol Med. 2016 Mar 31;8(4):388-406
pubmed: 26951623
Breast Cancer Res Treat. 2013 Feb;138(1):241-8
pubmed: 23371505
Am Soc Clin Oncol Educ Book. 2019 Jan;39:165-174
pubmed: 31099649
Int J Cancer. 2015 Apr 15;136(8):1803-13
pubmed: 25187059
J Clin Invest. 2014 Sep;124(9):3901-12
pubmed: 25133426
Int J Biochem Cell Biol. 2016 Dec;81(Pt A):223-232
pubmed: 27771439
Development. 1992 May;115(1):49-58
pubmed: 1638991
Int J Cancer. 2018 Jun 1;142(11):2273-2285
pubmed: 29330856
J Mammary Gland Biol Neoplasia. 2007 Mar;12(1):25-35
pubmed: 17431797
BMC Public Health. 2011 Apr 13;11 Suppl 3:S15
pubmed: 21501432
Cancer Res. 2018 Nov 15;78(22):6473-6485
pubmed: 30254150
Breast Cancer Res. 2019 Jul 17;21(1):80
pubmed: 31315645
Mol Carcinog. 2004 Dec;41(4):207-20
pubmed: 15468292
Breastfeed Med. 2014 Jun;9(5):239-43
pubmed: 24911394
Breast Cancer Res. 2004;6(2):R92-109
pubmed: 14979921
J Immunol. 2018 Jul 15;201(2):734-746
pubmed: 29884705
Genes Dev. 2011 Dec 15;25(24):2559-72
pubmed: 22190457
J Cell Sci. 2013 Sep 15;126(Pt 18):4108-10
pubmed: 23843613
Nat Methods. 2012 Jun 28;9(7):676-82
pubmed: 22743772
Acta Paediatr. 2015 Dec;104(467):96-113
pubmed: 26172878
J Clin Med. 2017 Jan 13;6(1):
pubmed: 28098775
Nat Rev Cancer. 2006 Apr;6(4):281-91
pubmed: 16557280
JCI Insight. 2017 Mar 23;2(6):e89206
pubmed: 28352652
Lancet. 2002 Jul 20;360(9328):187-95
pubmed: 12133652
Oncotarget. 2017 Jan 31;8(31):50731-50746
pubmed: 28881599
Breast Cancer Res Treat. 2013 Nov;142(1):165-75
pubmed: 24136668
Cancer Epidemiol Biomarkers Prev. 2011 Sep;20(9):1865-72
pubmed: 21750168
Diagn Pathol. 2007 Feb 27;2:8
pubmed: 17326824
Life Sci. 2014 Apr 25;102(1):10-5
pubmed: 24607778
Am J Pathol. 2014 Apr;184(4):1219-1229
pubmed: 24518566
J Clin Oncol. 2008 Jul 10;26(20):3324-30
pubmed: 18612148
Trends Endocrinol Metab. 2011 Jun;22(6):211-7
pubmed: 21592818
BMC Public Health. 2013;13 Suppl 3:S18
pubmed: 24564728
JAMA Netw Open. 2019 Jan 4;2(1):e186997
pubmed: 30646210
Am J Pathol. 1999 Feb;154(2):385-94
pubmed: 10027397
Annu Rev Immunol. 2003;21:107-37
pubmed: 12414720
Cancer Epidemiol Biomarkers Prev. 1994 Jun;3(4):353-64
pubmed: 8061586
Cancer. 2012 Jul 1;118(13):3226-8
pubmed: 22086839
Immunity. 2018 Mar 20;48(3):399-416
pubmed: 29562192
Maturitas. 2004 Sep 24;49(1):2-15
pubmed: 15351091
Pediatrics. 2006 Mar;117(3):e380-6
pubmed: 16510618
Int J Dev Biol. 2011;55(7-9):745-55
pubmed: 22161831
Cell Death Differ. 2016 Feb;23(2):185-96
pubmed: 26113040
Cell Rep. 2017 Apr 4;19(1):203-217
pubmed: 28380359
Obstet Gynecol. 2018 Jul;132(1):e35-e43
pubmed: 29781876
Cancer Res. 2000 Jul 1;60(13):3414-8
pubmed: 10910049
J Immunother Cancer. 2018 Oct 1;6(1):98
pubmed: 30285905
J Mammary Gland Biol Neoplasia. 2009 Jun;14(2):87-98
pubmed: 19381788
J Clin Oncol. 2009 Jan 1;27(1):45-51
pubmed: 19029418

Auteurs

Sonali Jindal (S)

Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, 2720 S Moody Avenue, Mailing Code: KR-CDCB, Portland, OR 97201 USA.
Knight Cancer Institute, Oregon Health & Science University, 2720 S Moody Avenue, Mailing Code: KR-ADM, Portland, OR 97201 USA.

Jayasri Narasimhan (J)

Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, 2720 S Moody Avenue, Mailing Code: KR-CDCB, Portland, OR 97201 USA.

Virginia F Borges (VF)

Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, MS8117, RC-1S, 8401K, 12801 E 17th Avenue, Aurora, CO 80045 USA.
Division of Medical Oncology, Young Women's Breast Cancer Translational Program, School of Medicine, University of Colorado Anschutz Medical Campus, MS8117, RC-1S, 8401K, 12801 E 17th Avenue, Aurora, CO 80045 USA.

Pepper Schedin (P)

Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, 2720 S Moody Avenue, Mailing Code: KR-CDCB, Portland, OR 97201 USA.
Knight Cancer Institute, Oregon Health & Science University, 2720 S Moody Avenue, Mailing Code: KR-ADM, Portland, OR 97201 USA.
Division of Medical Oncology, School of Medicine, University of Colorado Anschutz Medical Campus, MS8117, RC-1S, 8401K, 12801 E 17th Avenue, Aurora, CO 80045 USA.
Division of Medical Oncology, Young Women's Breast Cancer Translational Program, School of Medicine, University of Colorado Anschutz Medical Campus, MS8117, RC-1S, 8401K, 12801 E 17th Avenue, Aurora, CO 80045 USA.

Classifications MeSH